Arcellx Net Income
| ACLX Stock | USD 68.50 0.15 0.22% |
As of the 15th of February 2026, Arcellx shows the risk adjusted performance of (0.06), and Mean Deviation of 2.2. Arcellx technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Arcellx Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 98.9269 | Revenue | Earnings Share (3.93) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -169.8 M | -161.3 M | |
| Net Loss | -96.6 M | -101.4 M | |
| Net Loss | -96.6 M | -101.4 M | |
| Net Loss | (1.80) | (1.89) | |
| Net Income Per E B T | 0.92 | 0.81 |
Arcellx | Net Income | Build AI portfolio with Arcellx Stock |
The evolution of Net Income for Arcellx provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Arcellx compares to historical norms and industry peers.
Latest Arcellx's Net Income Growth Pattern
Below is the plot of the Net Income of Arcellx over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Arcellx financial statement analysis. It represents the amount of money remaining after all of Arcellx operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Arcellx's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcellx's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (107.35 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Arcellx Net Income Regression Statistics
| Arithmetic Mean | (44,325,945) | |
| Coefficient Of Variation | (118.85) | |
| Mean Deviation | 42,676,046 | |
| Median | (8,308,000) | |
| Standard Deviation | 52,681,270 | |
| Sample Variance | 2775.3T | |
| Range | 180.4M | |
| R-Value | (0.76) | |
| Mean Square Error | 1271.5T | |
| R-Squared | 0.57 | |
| Significance | 0.0005 | |
| Slope | (7,879,792) | |
| Total Sum of Squares | 44405.1T |
Arcellx Net Income History
Other Fundumenentals of Arcellx
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Arcellx Net Income component correlations
Arcellx Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Arcellx is extremely important. It helps to project a fair market value of Arcellx Stock properly, considering its historical fundamentals such as Net Income. Since Arcellx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Arcellx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Arcellx's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcellx. If investors know Arcellx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Arcellx assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.93) | Revenue Per Share | Quarterly Revenue Growth (0.81) | Return On Assets | Return On Equity |
The market value of Arcellx is measured differently than its book value, which is the value of Arcellx that is recorded on the company's balance sheet. Investors also form their own opinion of Arcellx's value that differs from its market value or its book value, called intrinsic value, which is Arcellx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcellx's market value can be influenced by many factors that don't directly affect Arcellx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Arcellx's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Arcellx represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Arcellx's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Arcellx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arcellx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arcellx.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Arcellx on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Arcellx or generate 0.0% return on investment in Arcellx over 90 days. Arcellx is related to or competes with Alkermes Plc, NewAmsterdam Pharma, Protagonist Therapeutics, Arrowhead Pharmaceuticals, Kymera Therapeutics, Viking Therapeutics, and Immunovant. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patient... More
Arcellx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arcellx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arcellx upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 22.18 | |||
| Value At Risk | (4.57) | |||
| Potential Upside | 4.75 |
Arcellx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcellx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arcellx's standard deviation. In reality, there are many statistical measures that can use Arcellx historical prices to predict the future Arcellx's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (15.41) |
Arcellx February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (15.40) | |||
| Mean Deviation | 2.2 | |||
| Coefficient Of Variation | (1,189) | |||
| Standard Deviation | 3.34 | |||
| Variance | 11.17 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (15.41) | |||
| Maximum Drawdown | 22.18 | |||
| Value At Risk | (4.57) | |||
| Potential Upside | 4.75 | |||
| Skewness | (1.64) | |||
| Kurtosis | 8.5 |
Arcellx Backtested Returns
Arcellx secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of standard deviation over the last 3 months. Arcellx exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arcellx's risk adjusted performance of (0.06), and Mean Deviation of 2.2 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0189, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Arcellx's returns are expected to increase less than the market. However, during the bear market, the loss of holding Arcellx is expected to be smaller as well. At this point, Arcellx has a negative expected return of -0.39%. Please make sure to confirm Arcellx's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Arcellx performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.8 |
Almost perfect reverse predictability
Arcellx has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Arcellx time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arcellx price movement. The serial correlation of -0.8 indicates that around 80.0% of current Arcellx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.8 | |
| Spearman Rank Test | -0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 5.28 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Arcellx Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Arcellx reported net income of (107.35 Million). This is 131.45% lower than that of the Biotechnology sector and 253.25% lower than that of the Health Care industry. The net income for all United States stocks is 118.8% higher than that of the company.
Arcellx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arcellx's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arcellx could also be used in its relative valuation, which is a method of valuing Arcellx by comparing valuation metrics of similar companies.Arcellx is currently under evaluation in net income category among its peers.
Arcellx ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Arcellx's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Arcellx's managers, analysts, and investors.Environmental | Governance | Social |
Arcellx Institutional Holders
Institutional Holdings refers to the ownership stake in Arcellx that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Arcellx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arcellx's value.| Shares | T. Rowe Price Associates, Inc. | 2025-06-30 | 1.4 M | Aju Ib Investment Co Ltd | 2025-06-30 | 1 M | Hhg Plc | 2025-06-30 | 1 M | Jpmorgan Chase & Co | 2025-06-30 | 977 K | Geode Capital Management, Llc | 2025-06-30 | 961.8 K | Cormorant Asset Management, Llc | 2025-06-30 | 800 K | Capital World Investors | 2025-06-30 | 783 K | Decheng Capital Llc | 2025-06-30 | 547.6 K | Bamco Inc | 2025-06-30 | 518 K | Fmr Inc | 2025-06-30 | 6 M | Paradigm Biocapital Advisors Lp | 2025-06-30 | 4.6 M |
Arcellx Fundamentals
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (12.48) % | ||||
| Current Valuation | 3.55 B | ||||
| Shares Outstanding | 57.82 M | ||||
| Shares Owned By Insiders | 12.91 % | ||||
| Shares Owned By Institutions | 87.09 % | ||||
| Number Of Shares Shorted | 9.11 M | ||||
| Price To Book | 8.99 X | ||||
| Price To Sales | 110.34 X | ||||
| Revenue | 107.94 M | ||||
| Gross Profit | (132.27 M) | ||||
| EBITDA | (99.06 M) | ||||
| Net Income | (107.35 M) | ||||
| Cash And Equivalents | 306.99 M | ||||
| Cash Per Share | 7.01 X | ||||
| Total Debt | 54.08 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 10.16 X | ||||
| Book Value Per Share | 7.63 X | ||||
| Cash Flow From Operations | (83.47 M) | ||||
| Short Ratio | 9.84 X | ||||
| Earnings Per Share | (3.93) X | ||||
| Price To Earnings To Growth | (0.07) X | ||||
| Target Price | 110.53 | ||||
| Number Of Employees | 163 | ||||
| Beta | 0.36 | ||||
| Market Capitalization | 3.96 B | ||||
| Total Asset | 711.33 M | ||||
| Retained Earnings | (496.83 M) | ||||
| Working Capital | 473.9 M | ||||
| Net Asset | 711.33 M |
About Arcellx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arcellx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arcellx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arcellx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Arcellx Stock Analysis
When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.